Background illustration for clinical trials search

Paid Clinical Trials Cincinnati

Discover 1,164 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

for
Geographic Atrophy, Macular Degeneration
Location: Cincinnati OH, Carmel IN, Cleveland OH, Lemont IL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 60+

Code: NCT06635148

Phase2, Phase3, Recruiting

Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

for
Proliferative Vitreoretinopathy,
Location: Cincinnati OH
Sponsor: Cincinnati Eye Institute, Southwest Ohio

Sex: All

Age: 18+

Code: NCT06541574

Phase2, Recruiting

A Prospective Longitudinal Analysis of Faricimab (Vabysmo 6mg) For Choroidal Neovascularization in Presumed Ocular Histoplasmosis Syndrome

for
Presumed Ocular Histoplasmosis
Location: Cincinnati OH, Dayton OH
Sponsor: Cincinnati Eye Institute, Southwest Ohio

Sex: All

Age: 18+

Code: NCT07695298

Recruiting

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

for
Macular Telangiectasia Type 2 (MacTel)
Location: Cincinnati OH, Knoxville TN, Cleveland OH, Chicago IL,
Sponsor: Neurotech Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06971939

Recruiting

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Cincinnati OH, Ann Arbor MI, Chicago IL, Pittsburgh PA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 6+

Code: NCT07425574

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)

for
ARB, BVMD, Autosomal-Dominant Bestrophinopathy,
Location: Cincinnati OH, Dallas TX, Los Angeles CA
Sponsor: Opus Genetics, Inc

Sex: All

Age: 18+

Code: NCT07185256

Phase1, Phase2, Recruiting

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

for
Corneal Transplant Failure
Location: Cincinnati OH, Indianapolis IN, Ann Arbor MI, Durham NC,
Sponsor: Massachusetts Eye and Ear Infirmary

Sex: All

Age: 18+

Code: NCT06753916

Phase2, Recruiting

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

for
Neovascular Age-Related Macular Degeneration (nAMD)
Location: Cincinnati OH, Carmel IN, Nashville TN, Oak Forest IL,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 50+

Code: NCT07064759

Phase3, Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Location: Cincinnati OH, Louisville KY, Dublin OH, Columbus OH,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT06541704

Phase3, Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for
Advanced Cancer, Metastatic Cancer, Ovarian Cancer,
Location: Cincinnati OH, Indianapolis IN, Maumee OH, Nashville TN,
Sponsor: Artios Pharma Ltd

Sex: All

Age: 18+

Code: NCT04657068

Phase1, Phase2, Recruiting

Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)

for
Carotid Artery Calcification, Carotid Artery Diseases
Location: Cincinnati OH, Park Ridge IL, Saginaw MI, Bay City MI,
Sponsor: Shockwave Medical, Inc.

Sex: All

Age: 18+

Code: NCT07062471

Recruiting

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

for
Glaucoma
Location: Cincinnati OH
Sponsor: Glaukos Corporation

Sex: All

Age: 35+

Code: NCT06057051

Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

for
Alzheimer's Disease
Location: Blue Ash OH, Atlanta GA, Morehead City NC,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT07011745

Phase3, Recruiting

An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome

for
Phelan-McDermid Syndrome
Location: Cincinnati OH, Chevy Chase MD, Lexington MA, Houston TX,
Sponsor: Neuren Pharmaceuticals Limited

Sex: All

Age: 3 - 12

Code: NCT07593391

Phase3, Recruiting

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

for
Pneumococcal Disease
Location: Cincinnati OH, Dayton OH, Allen Park MI,
Sponsor: Pfizer

Sex: All

Age: 0

Code: NCT07629440

Phase3, Recruiting

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

for
Narcolepsy, Idiopathic Hypersomnia
Location: Cincinnati OH, Dublin OH, Los Angeles CA
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07625280

Phase3, Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Cincinnati OH, Columbus OH, Urbana IL, Nashville TN,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase3, Recruiting

A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age

for
Chickenpox
Location: Cincinnati OH, Chicago IL, Richmond VA, Mankato MN,
Sponsor: GlaxoSmithKline

Sex: All

Age: 1

Code: NCT06693895

Phase3, Recruiting

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

for
Idiopathic Hypersomnia
Location: Cincinnati OH, Canton OH, Cleveland OH, Lansing MI,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT06843590

Phase2, Recruiting

A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Cincinnati OH, Dublin OH, Cleveland OH, Southfield MI,
Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All

Age: 18 - 65

Code: NCT06752668

Phase2, Recruiting